04/01/2024 5:04 AM | CymaBay Therapeutics (Filer)
| Form 15-12G | |
03/28/2024 11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/28/2024 11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/28/2024 11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/28/2024 11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/28/2024 11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/22/2024 3:54 PM | CymaBay Therapeutics (Filer)
| Form S-8 POS | |
|
03/22/2024 3:54 PM | CymaBay Therapeutics (Issuer) WIGGANS THOMAS G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:55 PM | CymaBay Therapeutics (Issuer) Shah Sujal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:55 PM | CymaBay Therapeutics (Issuer) Wills Robert James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:55 PM | CymaBay Therapeutics (Filer)
| Form S-8 POS | |
03/22/2024 3:56 PM | CymaBay Therapeutics (Filer)
| Form S-8 POS | |
03/22/2024 3:58 PM | CymaBay Therapeutics (Filer)
| Form S-8 POS | |
03/22/2024 3:59 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:02 PM | CymaBay Therapeutics (Issuer) Dickinson Klara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:03 PM | CymaBay Therapeutics (Issuer) Shantharam Harish (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:03 PM | CymaBay Therapeutics (Issuer) Dorling Janet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:05 PM | CymaBay Therapeutics (Issuer) Lefebvre Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:06 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:09 PM | CymaBay Therapeutics (Issuer) Loewy Caroline M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:28 PM | CymaBay Therapeutics (Filer)
| Form POSASR | |
03/22/2024 3:31 PM | CymaBay Therapeutics (Filer)
| Form POSASR | |
03/22/2024 9:53 AM | CymaBay Therapeutics (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
03/22/2024 8:22 AM | CymaBay Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/22/2024 6:50 AM | CymaBay Therapeutics (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T/A | |
03/22/2024 6:56 AM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
03/20/2024 3:24 PM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
03/20/2024 3:12 PM | CymaBay Therapeutics (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T/A | |
03/15/2024 3:11 PM | CymaBay Therapeutics (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T/A | |
03/15/2024 3:12 PM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
03/11/2024 8:14 AM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
03/11/2024 7:34 AM | CymaBay Therapeutics (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T/A | |
03/07/2024 3:35 PM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
02/28/2024 3:31 PM | CymaBay Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/23/2024 5:25 AM | CymaBay Therapeutics (Subject)
| Form SC 14D9 | |
02/23/2024 5:09 AM | CymaBay Therapeutics (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T | |
02/16/2024 4:14 PM | CymaBay Therapeutics (Subject)
| Form SC14D9C | |
02/15/2024 3:15 PM | CymaBay Therapeutics (Subject) Menold Daniel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 5:43 PM | CymaBay Therapeutics (Issuer) Dorling Janet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:46 PM | CymaBay Therapeutics (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 11:50 AM | CymaBay Therapeutics (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
Exposed: 10 CENT Crypto to Explode April 20th? (Ad) The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%...
Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 |
02/14/2024 8:09 AM | Avoro Capital Advisors LLC (Filed by) CymaBay Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024 4:29 PM | CymaBay Therapeutics (Subject)
| Form SC14D9C | |
02/12/2024 7:42 AM | CymaBay Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 7:45 AM | CymaBay Therapeutics (Subject)
| Form SC14D9C | |
02/12/2024 7:39 AM | CymaBay Therapeutics (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-C | |
02/06/2024 4:38 PM | CymaBay Therapeutics (Subject) STUART LEWIS J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 4:00 PM | CymaBay Therapeutics (Subject) Menold Daniel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024 5:33 PM | CymaBay Therapeutics (Subject) Menold Daniel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024 4:59 PM | CymaBay Therapeutics (Subject) Menold Daniel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/26/2024 5:10 PM | CymaBay Therapeutics (Issuer) EMSTER KURT VON (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:16 PM | CymaBay Therapeutics (Issuer) Lefebvre Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:17 PM | CymaBay Therapeutics (Issuer) Loewy Caroline M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:18 PM | CymaBay Therapeutics (Issuer) WIGGANS THOMAS G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:19 PM | CymaBay Therapeutics (Issuer) Dorling Janet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:20 PM | CymaBay Therapeutics (Issuer) Wills Robert James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:27 PM | CymaBay Therapeutics (Issuer) Shah Sujal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:28 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:29 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:30 PM | CymaBay Therapeutics (Issuer) Dickinson Klara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:33 PM | CymaBay Therapeutics (Issuer) Shantharam Harish (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 5:59 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 3:33 PM | CymaBay Therapeutics (Subject) STUART LEWIS J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024 6:15 PM | CymaBay Therapeutics (Subject) McWherter Charles (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024 3:44 PM | CymaBay Therapeutics (Subject) STUART LEWIS J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 3:39 PM | CymaBay Therapeutics (Subject) STUART LEWIS J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024 3:54 PM | CymaBay Therapeutics (Subject) STUART LEWIS J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 6:07 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 6:07 PM | CymaBay Therapeutics (Issuer) Menold Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 3:23 PM | CymaBay Therapeutics (Subject) Menold Daniel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 3:24 PM | CymaBay Therapeutics (Subject) Quinlan Paul T (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024 7:35 PM | CymaBay Therapeutics (Issuer) Dorling Janet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 3:11 PM | CymaBay Therapeutics (Subject) Dorling Janet (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2024 3:50 PM | CymaBay Therapeutics (Subject) STUART LEWIS J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023 7:04 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 3:35 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 3:38 PM | CymaBay Therapeutics (Issuer) Menold Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:01 PM | CymaBay Therapeutics (Issuer) Dorling Janet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:03 PM | CymaBay Therapeutics (Issuer) Shah Sujal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 3:39 PM | CymaBay Therapeutics (Subject) Shah Sujal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023 4:57 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/17/2023 4:57 PM | CymaBay Therapeutics (Issuer) Menold Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/17/2023 4:58 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 4:56 PM | CymaBay Therapeutics (Issuer) Dorling Janet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 5:00 PM | CymaBay Therapeutics (Issuer) Shah Sujal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 8:08 AM | CymaBay Therapeutics (Subject) Dorling Janet (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2023 5:21 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 5:22 PM | CymaBay Therapeutics (Issuer) Menold Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 5:22 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2023 3:16 PM | CymaBay Therapeutics (Subject) Quinlan Paul T (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2023 3:16 PM | CymaBay Therapeutics (Subject) Menold Daniel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Exposed: 10 CENT Crypto to Explode April 20th? (Ad) The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%...
Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 |
10/10/2023 4:04 PM | CymaBay Therapeutics (Issuer) Shah Sujal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/10/2023 7:55 AM | CymaBay Therapeutics (Subject) Shah Sujal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/29/2023 4:54 PM | CymaBay Therapeutics (Issuer) EMSTER KURT VON (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 3:54 PM | CymaBay Therapeutics (Subject) EMSTER KURT VON (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023 3:30 PM | CymaBay Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
09/19/2023 4:23 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 4:25 PM | CymaBay Therapeutics (Issuer) Menold Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 4:27 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 3:04 PM | CymaBay Therapeutics (Subject) McWherter Charles (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |